Ambassador Advisors, LLC Dexcom Inc Transaction History

Ambassador Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $122,942 - $163,837	-1,518 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $128,711 - $158,995	1,518 New	1,518 $546,000
Q4 2020 Feb 17, 2021	SELL	$78.0 - $104.5 $766,662 - $1.03 Million	-9,829 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $64,278 - $76,015	673 Added 7.35%	9,829 $4.05 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $573,898 - $964,493	9,156 New	9,156 $3.71 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ambassador Advisors, LLC with notifications on news.